165 related articles for article (PubMed ID: 9767237)
1. Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects.
Smith CH; Allen MH; Groves RW; Barker JN
Br J Dermatol; 1998 Aug; 139(2):239-46. PubMed ID: 9767237
[TBL] [Abstract][Full Text] [Related]
2. Intradermal granulocyte-macrophage colony-stimulating factor alters cutaneous antigen-presenting cells and differentially affects local versus distant immunization in humans.
Kremer IB; Stevens SR; Gould JW; DiCarlo J; Quinby GE; Cooper KD
Clin Immunol; 2000 Jul; 96(1):29-37. PubMed ID: 10873425
[TBL] [Abstract][Full Text] [Related]
3. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.
Kaplan G; Walsh G; Guido LS; Meyn P; Burkhardt RA; Abalos RM; Barker J; Frindt PA; Fajardo TT; Celona R
J Exp Med; 1992 Jun; 175(6):1717-28. PubMed ID: 1588289
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently.
Ozawa H; Nakagawa S; Tagami H; Aiba S
J Invest Dermatol; 1996 Mar; 106(3):441-5. PubMed ID: 8648174
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte macrophage--colony-stimulating factor (GM-CSF) decreases CD1a expression by human Langerhans cells and increases proliferation in the mixed epidermal cell-lymphocyte reaction (MELR).
Kolenik S; Ding TG; Longley J
J Invest Dermatol; 1990 Sep; 95(3):359-62. PubMed ID: 1696605
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression.
Groves RW; Allen MH; Ross EL; Barker JN; MacDonald DM
Br J Dermatol; 1995 Mar; 132(3):345-52. PubMed ID: 7536438
[TBL] [Abstract][Full Text] [Related]
7. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers.
Tazi A; Bouchonnet F; Grandsaigne M; Boumsell L; Hance AJ; Soler P
J Clin Invest; 1993 Feb; 91(2):566-76. PubMed ID: 7679411
[TBL] [Abstract][Full Text] [Related]
8. Langerhans' cell expression of the selectin ligand, sialyl Lewis x.
Ross EL; Barker JN; Allen MH; Chu AC; Groves RW; MacDonald DM
Immunology; 1994 Feb; 81(2):303-8. PubMed ID: 7512530
[TBL] [Abstract][Full Text] [Related]
9. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.
Janik JE; Miller LL; Kopp WC; Taub DD; Dawson H; Stevens D; Kostboth P; Curti BD; Conlon KC; Dunn BK; Donegan SE; Ullrich R; Alvord WG; Gause BL; Longo DL
Clin Immunol; 1999 Dec; 93(3):209-21. PubMed ID: 10600331
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of HLA class II, but not intercellular adhesion molecule 1 (ICAM-1) by granulocyte-macrophage colony stimulating factor (GM-CSF) or interleukin-3 (IL-3) in synergy with dexamethasone.
Sadeghi R; Feldmann M; Hawrylowicz C
Eur Cytokine Netw; 1992; 3(4):373-80. PubMed ID: 1358241
[TBL] [Abstract][Full Text] [Related]
11. Modulation of MHC class II+ Langerhans cell numbers in corticosteroid treated epidermis by GM-CSF in combination with TNF-alpha.
O'Sullivan GM; Halliday GM
Exp Dermatol; 1997 Oct; 6(5):236-42. PubMed ID: 9450626
[TBL] [Abstract][Full Text] [Related]
12. In situ behavior of human Langerhans cells in skin organ culture.
Rambukkana A; Bos JD; Irik D; Menko WJ; Kapsenberg ML; Das PK
Lab Invest; 1995 Oct; 73(4):521-31. PubMed ID: 7474924
[TBL] [Abstract][Full Text] [Related]
13. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X.
Tazi A; Bonay M; Bergeron A; Grandsaigne M; Hance AJ; Soler P
Thorax; 1996 Jun; 51(6):611-4. PubMed ID: 8693443
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous immune system].
Schmitt D
C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte/macrophage-colony-stimulating factor induces the migration of human epidermal Langerhans cells in vitro.
Rupec R; Magerstaedt R; Schirren CG; Sander E; Bieber T
Exp Dermatol; 1996 Apr; 5(2):115-9. PubMed ID: 8734921
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.
Cianfarani F; Tommasi R; Failla CM; Viviano MT; Annessi G; Papi M; Zambruno G; Odorisio T
Br J Dermatol; 2006 Jan; 154(1):34-41. PubMed ID: 16403091
[TBL] [Abstract][Full Text] [Related]
18. Effect of UVB 311 nm irradiation on normal human skin.
Viac J; Goujon C; Misery L; Staniek V; Faure M; Schmitt D; Claudy A
Photodermatol Photoimmunol Photomed; 1997 Jun; 13(3):103-8. PubMed ID: 9372527
[TBL] [Abstract][Full Text] [Related]
19. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
20. Intradermal transgenic expression of granulocyte-macrophage colony-stimulating factor induces neutrophilia, epidermal hyperplasia, Langerhans' cell/macrophage accumulation, and dermal fibrosis.
Xing Z; Gauldie J; Tremblay GM; Hewlett BR; Addison C
Lab Invest; 1997 Dec; 77(6):615-22. PubMed ID: 9426399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
